In Brief: FDA Office of International Affairs
FDA Office of International Affairs: Director Walter Batts will report to Deputy Commissioner for External Affairs Sharon Smith Holston in an effort to elevate the office and clarify its activities. Batts will no longer report to Office of Health Affairs Director Stuart Nightingale, MD, who retains responsibilities for areas related to the World Health Organization and International Conference on Harmonization...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth